Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hypoxia induces sorafenib resistance mediated by autophagy via activating FOXO3a in hepatocellular carcinoma
Chao Liang, Zhebin Dong, Xianlei Cai, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 11
Open Access | Times Cited: 61

Showing 1-25 of 61 citing articles:

Targeting the PI3K/Akt/mTOR Pathway in Hepatocellular Carcinoma
Eun Jin Sun, Miriam Wankell, Pranavan Palamuthusingam, et al.
Biomedicines (2021) Vol. 9, Iss. 11, pp. 1639-1639
Open Access | Times Cited: 178
New insights into antiangiogenic therapy resistance in cancer: Mechanisms and therapeutic aspects
Maohua Huang, Yuning Lin, Chenran Wang, et al.
Drug Resistance Updates (2022) Vol. 64, pp. 100849-100849
Closed Access | Times Cited: 96
FOXO3A-induced LINC00926 suppresses breast tumor growth and metastasis through inhibition of PGK1-mediated Warburg effect
Zhong Chu, Nan Huo, Xiang Zhu, et al.
Molecular Therapy (2021) Vol. 29, Iss. 9, pp. 2737-2753
Open Access | Times Cited: 85
FOXO3a in cancer drug resistance
Ying Liu, Yu Wang, Xiaoge Li, et al.
Cancer Letters (2022) Vol. 540, pp. 215724-215724
Closed Access | Times Cited: 54
RBM47/SNHG5/FOXO3 axis activates autophagy and inhibits cell proliferation in papillary thyroid carcinoma
Yuan Qin, Wei Sun, Zhihong Wang, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 3
Open Access | Times Cited: 47
Transcriptional regulation of autophagy and its implications in human disease
Yuchen Lei, Daniel J. Klionsky
Cell Death and Differentiation (2023) Vol. 30, Iss. 6, pp. 1416-1429
Closed Access | Times Cited: 33
Targeting and regulation of autophagy in hepatocellular carcinoma: revisiting the molecular interactions and mechanisms for new therapy approaches
Mehrdad Hashemi, Niloufar Nadafzadeh, Mohammad Hassan Imani, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 29
Nanomedicine Strategies in Conquering and Utilizing the Cancer Hypoxia Environment
Yi Pan, Longcai Liu, Xiaozhou Mou, et al.
ACS Nano (2023) Vol. 17, Iss. 21, pp. 20875-20924
Closed Access | Times Cited: 26
Complex roles of autophagy in cancer development, immune evasion, and drug resistance
Xuegang Niu, Qi Sheng You, Kejun Hou, et al.
Drug Resistance Updates (2024) Vol. 78, pp. 101170-101170
Closed Access | Times Cited: 14
New Opportunities in the Systemic Treatment of Hepatocellular Carcinoma—Today and Tomorrow
Rafał Becht, Kajetan Kiełbowski, Michał Wasilewicz
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1456-1456
Open Access | Times Cited: 8
Elucidating the Molecular Basis of Sorafenib Resistance in HCC: Current Findings and Future Directions
Francesca Fornari, Catia Giovannini, Fabio Piscaglia, et al.
Journal of Hepatocellular Carcinoma (2021) Vol. Volume 8, pp. 741-757
Open Access | Times Cited: 46
Recent progress of autophagy signaling in tumor microenvironment and its targeting for possible cancer therapeutics
Subhadip Mukhopadhyay, Kewal Kumar Mahapatra, Prakash Priyadarshi Praharaj, et al.
Seminars in Cancer Biology (2021) Vol. 85, pp. 196-208
Closed Access | Times Cited: 46
Hyperbaric oxygen facilitates teniposide-induced cGAS-STING activation to enhance the antitumor efficacy of PD-1 antibody in HCC
Kun Li, Yihang Gong, Dongbo Qiu, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 8, pp. e004006-e004006
Open Access | Times Cited: 30
MiRNA-124-3p.1 sensitizes hepatocellular carcinoma cells to sorafenib by regulating FOXO3a by targeting AKT2 and SIRT1
Zhebin Dong, Hengmiao Wu, Yi-cheng He, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 29
Autophagy orchestrates resistance in hepatocellular carcinoma cells
Homeyra Seydi, Kosar Nouri, Niloufar Rezaei, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114487-114487
Open Access | Times Cited: 21
Ets1 mediates sorafenib resistance by regulating mitochondrial ROS pathway in hepatocellular carcinoma
Kanchan Vishnoi, Rong Ke, Navin Viswakarma, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 7
Open Access | Times Cited: 24
Co‐Delivery of siNRF2 and Sorafenib by a “Click” Dual Functioned Hyperbranched Nanocarrier for Synergistically Inducing Ferroptosis in Hepatocellular Carcinoma
Rongliang Tong, Xiaode Feng, Jingqi Sun, et al.
Small (2023) Vol. 20, Iss. 21
Closed Access | Times Cited: 14
Transcriptional dysregulation of autophagy in the muscle of a mouse model of Duchenne muscular dystrophy
Ryuta Nakashima, Ryusuke Hosoda, Yuki Tatekoshi, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Investigating autophagy and intricate cellular mechanisms in hepatocellular carcinoma: Emphasis on cell death mechanism crosstalk
Gang Wang, Xiaodi Jiang, Pedram Torabian, et al.
Cancer Letters (2024) Vol. 588, pp. 216744-216744
Open Access | Times Cited: 5
Unraveling the triad of hypoxia, cancer cell stemness, and drug resistance
Tongxuan Shang, Ziqi Jia, J. Li, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access
Sorafenib resistance and therapeutic strategies in hepatocellular carcinoma
Weijing Zhang, Xuechuan Hong, Yuling Xiao, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189310-189310
Closed Access
Cancer stem cells, epithelial-mesenchymal transition, ATP and their roles in drug resistance in cancer
Haiyun Zhang, Alexander Steed, Milo Co, et al.
Cancer Drug Resistance (2021)
Open Access | Times Cited: 32
Synergetic treatment of oxygen microcapsules and lenvatinib for enhanced therapy of HCC by alleviating hypoxia condition and activating anti-tumor immunity
Jianpeng Sheng, Jiangchao Wu, Xianghong Yin, et al.
Chinese Chemical Letters (2022) Vol. 34, Iss. 4, pp. 107738-107738
Closed Access | Times Cited: 20
Crebanine induces ROS-dependent apoptosis in human hepatocellular carcinoma cells via the AKT/FoxO3a signaling pathway
Jiajie Tan, Yuling Xiang, Yuanguo Xiong, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 12
Hypoxia-Inducible Factor-Dependent and Independent Mechanisms Underlying Chemoresistance of Hypoxic Cancer Cells
Peter Wai Tik Lee, Lina Rochelle Koseki, Takao Haitani, et al.
Cancers (2024) Vol. 16, Iss. 9, pp. 1729-1729
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top